> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-242/
- Published: 2019-10-13T12:00:00.000Z
- Updated: 2026-09-15T01:56:08.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145243

[**CDRH Listing on Upcoming Guidance Documents**](https://www.fdaweb.com/cdrh-listing-on-upcoming-guidance-documents/)  
*Federal Register* notice: FDA announces its Web site address where CDRH will post two lists of guidance documents that the Center intends to publish in fiscal year 2020\. 10/11/2019

[**Info Collection on 510(k) 3rd-party Reviews**](https://www.fdaweb.com/info-collection-on-510-k-3rd-party-reviews/)  
*Federal Register* notice: FDA submits to OMB an information collection extension for “510(k) Third-Party Review Program.” 10/11/2019

[**Info Collection Extension for CVM eSubmissions**](https://www.fdaweb.com/info-collection-extension-for-cvm-esubmissions/)  
*Federal Register* notice: FDA sends to OMB an information collection extension for a guidance on cvm’s electronic submission system. 10/11/2019

[**Info Collection Extension for Outsourcing Facilities**](https://www.fdaweb.com/info-collection-extension-for-outsourcing-facilities/)  
*Federal Register* notice: FDA submits to OMB an information collection extension for electronic drug product reporting for drug compounding outsourcing facilities. 10/10/2019

[**Final Guide on Intravascular Catheter Labeling**](https://www.fdaweb.com/final-guide-on-intravascular-catheter-labeling/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Intravascular Catheters, Wires, and Delivery Systems with Lubricious Coatings-Labeling Considerations.” 10/10/2019

[**Guide on Guidewire Testing and Labeling**](https://www.fdaweb.com/guide-on-guidewire-testing-and-labeling/)  
*Federal Register* notice: FDA makes available a final guidance on coronary, peripheral, and neurovascular guidewire testing and labeling. 10/10/2019

[**Final Guide on IVDs in Oncology Trials**](https://www.fdaweb.com/final-guide-on-ivds-in-oncology-trials/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Investigational In Vitro Diagnostics in Oncology Trials: Streamlined Submission Process for Study Risk Determination.” 10/10/2019

[**Workshop on Pediatric Clinical Trial Endpoints**](https://www.fdaweb.com/workshop-on-pediatric-clinical-trial-endpoints/)  
*Federal Register* notice: FDA announces an 11/12 public workshop on patient perspectives in pediatric clinical trial endpoints for rare diseases. 10/09/2019

[**Priority Voucher Awarded to Bavarian Nordic**](https://www.fdaweb.com/priority-voucher-awarded-to-bavarian-nordic/)  
*Federal Register* notice: FDA announces that it has issued a material threat medical countermeasure priority review voucher to Bavarian Nordic for recently approved Jynneos (smallpox and monkeypox vaccine). 10/09/2019

[**New Info Collection on FDA Fellowship Programs**](https://www.fdaweb.com/new-info-collection-on-fda-fellowship-programs/)  
*Federal Register* notice: FDA submits to OMB a new information collection conflict of interest information for non-employee fellowship programs participants. 10/08/2019